This brand name is authorized in Brazil, Ecuador, France, Hong Kong SAR China, Malta, Mexico, Singapore, Turkey.
The drug ARCALION contains one active pharmaceutical ingredient (API):
1
|
UNII
42NCM1BW43 - SULBUTIAMINE
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A11DA02 | Sulbutiamine | A Alimentary tract and metabolism → A11 Vitamins → A11D Vitamin B1, plain and in combination with vitamin B6 and B12 → A11DA Vitamin B1, plain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 531316050007503, 531316050007703 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 15.765-3-09-05 |
| FR | Base de données publique des médicaments | 64384738 |
| HK | Department of Health Drug Office | 19244 |
| MT | Medicines Authority | MA066/00201 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 538M2004 |
| SG | Health Sciences Authority | 06159P |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699552120315 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.